Comparison of 4.0 mg/kg Sugammadex at 1-2 Post Tetanic Counts (PTC) in Renal or Control Patients (19.4.328)(P05769)
NCT00702715
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
69
Enrollment
INDUSTRY
Sponsor class
Conditions
Anesthesia
Interventions
DRUG:
sugammadex
Sponsor
Merck Sharp & Dohme LLC